Convertible Note and Derivative Liabilities (Details Narrative) - USD ($)	1 Months Ended						12 Months Ended
	Jun. 15, 2024	Jun. 15, 2023	Jun. 15, 2022	Jun. 15, 2021	Feb. 19, 2020	Dec. 31, 2019	Dec. 31, 2024	Dec. 31, 2023
Accounts payable and accrued liabilities							$ 124,966	$ 155,357
Accrued interest	$ 16,000	$ 162,000	$ 124,200
Accrued interest outstanding	$ 300,000	$ 243,000	$ 186,300
Warrant maturity date	Jun. 15, 2025	Jun. 15, 2028	Jun. 15, 2027
Restricted common stock valued	$ 55,644	$ 52,500	$ 76,350
Issuance of common stock shares		150,000	$ 150,000
Quick Capital outstanding balance		243,000
Net quick Capital		$ 200,000
Interest rate per annum							8.00%
Purchase shares of common stock							800,000
Derivative Liabilities [Member]
Accounts payable and accrued liabilities							$ 32,086	25,669
Interest rate per annum					8.00%	8.00%
Purchase shares of common stock					10,000	70,000
Conversion, description					The note is due on February 19, 2022 and is convertible into shares of common stock at a conversion price per share equal to the lesser of: (a) $0.50; (b) the lowest price at which the Company has converted any convertible security of the Company within 30 trading days prior to the date of delivery of the applicable notice of conversion; or (c) such other price as the Company and the holder may agree. In connection with the 8% convertible note issuance, we issued warrants to purchase an aggregate of 10,000 shares of common stock at an exercise price of $1.00	Such notes were due on December 31, 2021 and are convertible into shares of our common stock at a conversion price for each share of common stock equal to the lesser of: (a) $0.50; (b) the lowest price at which the Company has converted any convertible security of the Company (to the holder or to any third party) within 30 trading days prior to the date of delivery of the applicable notice of conversion; and (c) so long as lower than (a) or (b), such other price as the Company and the holder may agree. In connection with the 8% convertible note issuance, we issued warrants to purchase an aggregate of 70,000 shares of common stock at an exercise price of $1.00
Investment				$ 100,000
Legal and transaction expences				3,500
Principal amount				$ 115,000	$ 10,000	$ 70,000
Discount rate				10.00%
Aggregate purchase of common stock				115,000
Exercise price				$ 1.00	$ 1.00
Conversion price of common stock				$ 0.50
Liquidated damages payment, daily				$ 2,000
Interest due penalty				50.00%
Unpaid interest [Member]
Accounts payable and accrued liabilities							$ 9,421	$ 8,723